Lotte Vinge

1.2k total citations
10 papers, 179 citations indexed

About

Lotte Vinge is a scholar working on Neurology, Surgery and Physiology. According to data from OpenAlex, Lotte Vinge has authored 10 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 4 papers in Surgery and 3 papers in Physiology. Recurrent topics in Lotte Vinge's work include Myasthenia Gravis and Thymoma (8 papers), Parkinson's Disease and Spinal Disorders (6 papers) and Thyroid and Parathyroid Surgery (3 papers). Lotte Vinge is often cited by papers focused on Myasthenia Gravis and Thymoma (8 papers), Parkinson's Disease and Spinal Disorders (6 papers) and Thyroid and Parathyroid Surgery (3 papers). Lotte Vinge collaborates with scholars based in Denmark, Germany and Sweden. Lotte Vinge's co-authors include Henning Andersen, Kristian Overgaard, Ulrik Dalgas, Johannes Jakobsen, M. Laub, Thomas Harbo, Morten Dunø, Zoltán Lukács, Karen L. Madsen and Nicolai Preisler and has published in prestigious journals such as Muscle & Nerve, PeerJ and Acta Neurologica Scandinavica.

In The Last Decade

Lotte Vinge

8 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotte Vinge Denmark 7 109 54 50 24 18 10 179
Cintia Marchesoni Argentina 6 61 0.6× 124 2.3× 50 1.0× 23 1.0× 23 1.3× 15 175
Luciana León Cejas Argentina 8 65 0.6× 22 0.4× 13 0.3× 11 0.5× 3 0.2× 24 114
Miguel Rodrigues Portugal 5 45 0.4× 73 1.4× 36 0.7× 8 0.3× 21 1.2× 13 126
Foekje de Boer Netherlands 11 29 0.3× 77 1.4× 171 3.4× 35 1.5× 48 2.7× 15 223
Hiroshi Nakazora Japan 8 42 0.4× 21 0.4× 14 0.3× 42 1.8× 18 117
Magdalena Cerón‐Rodríguez Mexico 6 12 0.1× 55 1.0× 11 0.2× 16 0.7× 16 0.9× 13 85
Akın Nihat United Kingdom 9 34 0.3× 23 0.4× 17 0.3× 126 5.3× 18 228
Valtteri Oksanen Finland 7 36 0.3× 201 3.7× 17 0.3× 98 4.1× 7 0.4× 12 244
Gianmarco Bellucci Italy 8 84 0.8× 15 0.3× 14 0.3× 38 1.6× 18 213
Tiziana Tassinari Italy 7 41 0.4× 12 0.2× 18 0.4× 5 0.2× 2 0.1× 10 101

Countries citing papers authored by Lotte Vinge

Since Specialization
Citations

This map shows the geographic impact of Lotte Vinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Vinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Vinge more than expected).

Fields of papers citing papers by Lotte Vinge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Vinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Vinge. The network helps show where Lotte Vinge may publish in the future.

Co-authorship network of co-authors of Lotte Vinge

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Vinge. A scholar is included among the top collaborators of Lotte Vinge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Vinge. Lotte Vinge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vinge, Lotte, et al.. (2022). A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis. Neuromuscular Disorders. 32(4). 305–312. 2 indexed citations
2.
Vinge, Lotte, et al.. (2021). Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study. Muscle & Nerve. 64(5). 538–544. 23 indexed citations
3.
Vinge, Lotte, et al.. (2021). Overactive bladder in patients with myasthenia gravis—A cross‐sectional population‐based study. Acta Neurologica Scandinavica. 144(1). 76–80. 7 indexed citations
4.
Shimada, Akiko, et al.. (2021). Oral function in patients with myasthenia gravis. PeerJ. 9. e11680–e11680.
5.
Vinge, Lotte, Johannes Jakobsen, & Henning Andersen. (2018). Muscle weakness and functional disability in patients with myasthenia gravis. Muscle & Nerve. 59(2). 218–223. 13 indexed citations
6.
Overgaard, Kristian, et al.. (2017). Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle & Nerve. 56(4). 700–709. 54 indexed citations
7.
Vinge, Lotte & Henning Andersen. (2016). Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis. Muscle & Nerve. 54(4). 709–714. 9 indexed citations
8.
Vinge, Lotte, Johannes Jakobsen, Asger Roer Pedersen, & Henning Andersen. (2015). Diurnal and day‐to‐day variation of isometric muscle strength in myasthenia gravis. Muscle & Nerve. 53(1). 67–72. 9 indexed citations
9.
Preisler, Nicolai, Zoltán Lukács, Lotte Vinge, et al.. (2013). Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies. Molecular Genetics and Metabolism. 110(3). 287–289. 62 indexed citations
10.
Preisler, Nicolai, Karen L. Madsen, R. Hansen, et al.. (2011). P3.60 Pompe disease in persons with unclassified Limb-girdle muscular dystrophy. Neuromuscular Disorders. 21(9-10). 700–701.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026